BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20007782)

  • 1. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
    Takacs Z; Toups M; Kollewe A; Johnson E; Cuello LG; Driessens G; Biancalana M; Koide A; Ponte CG; Perozo E; Gajewski TF; Suarez-Kurtz G; Koide S; Goldstein SA
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22211-6. PubMed ID: 20007782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
    Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
    Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.
    Meng L; Xie Z; Zhang Q; Li Y; Yang F; Chen Z; Li W; Cao Z; Wu Y
    J Biol Chem; 2016 Mar; 291(13):7097-106. PubMed ID: 26817841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a function-specific mutation in the neurotoxin, parabutoxin 3.
    Huys I; Tytgat J
    Eur J Neurosci; 2003 May; 17(9):1786-92. PubMed ID: 12752777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
    Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
    J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of three toxin peptides with Kv1.3 channel and IL-2 cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus tricostatus and Chaerilus tryznai.
    Ding L; Chen J; Hao J; Zhang J; Huang X; Hu F; Wu Z; Liu Y; Li W; Cao Z; Wu Y; Li J; Li S; Liu H; Wu W; Chen Z
    Peptides; 2017 May; 91():13-19. PubMed ID: 28300672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new kappa-KTx 2.5 from the scorpion Opisthacanthus cayaporum.
    Camargos TS; Restano-Cassulini R; Possani LD; Peigneur S; Tytgat J; Schwartz CA; Alves EM; de Freitas SM; Schwartz EF
    Peptides; 2011 Jul; 32(7):1509-17. PubMed ID: 21624408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
    Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
    Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Kuzmenkov AI; Nekrasova OV; Peigneur S; Tabakmakher VM; Gigolaev AM; Fradkov AF; Kudryashova KS; Chugunov AO; Efremov RG; Tytgat J; Feofanov AV; Vassilevski AA
    Neuropharmacology; 2018 Dec; 143():228-238. PubMed ID: 30248306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
    Xie S; Feng J; Yu C; Li Z; Wu Y; Cao Z; Li W; He X; Xiang M; Han S
    Peptides; 2012 Jul; 36(1):94-9. PubMed ID: 22580271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
    Abdel-Mottaleb Y; Vandendriessche T; Clynen E; Landuyt B; Jalali A; Vatanpour H; Schoofs L; Tytgat J
    Toxicon; 2008 Jun; 51(8):1424-30. PubMed ID: 18471844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
    Legros C; Schulze C; Garcia ML; Bougis PE; Martin-Eauclaire MF; Pongs O
    Biochemistry; 2002 Dec; 41(51):15369-75. PubMed ID: 12484776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and structural characterization of Kunitz-type peptide LmKTT-1a highlights diversity and evolution of scorpion potassium channel toxins.
    Chen Z; Luo F; Feng J; Yang W; Zeng D; Zhao R; Cao Z; Liu M; Li W; Jiang L; Wu Y
    PLoS One; 2013; 8(4):e60201. PubMed ID: 23573241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.
    Gurrola GB; Hernández-López RA; Rodríguez de la Vega RC; Varga Z; Batista CV; Salas-Castillo SP; Panyi G; del Río-Portilla F; Possani LD
    Biochemistry; 2012 May; 51(19):4049-61. PubMed ID: 22540187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
    Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
    Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kv1.3 K
    Varga Z; Tajti G; Panyi G
    Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K
    Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
    Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designer and natural peptide toxin blockers of the KcsA potassium channel identified by phage display.
    Zhao R; Dai H; Mendelman N; Cuello LG; Chill JH; Goldstein SA
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E7013-21. PubMed ID: 26627718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.
    Kuzmenkov AI; Vassilevski AA; Kudryashova KS; Nekrasova OV; Peigneur S; Tytgat J; Feofanov AV; Kirpichnikov MP; Grishin EV
    J Biol Chem; 2015 May; 290(19):12195-209. PubMed ID: 25792741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.